Silence Therapeutics Reports on Shareholder Vote Matters
Ticker: SLNCF · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1479615
| Field | Detail |
|---|---|
| Company | Silence Therapeutics PLC (SLNCF) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Silence Therapeutics filed an 8-K about a shareholder vote on June 26th.
AI Summary
Silence Therapeutics plc filed an 8-K on June 27, 2025, reporting on matters submitted to a vote of security holders as of June 26, 2025. The filing does not contain specific details about the vote outcomes or the matters voted upon, only that such a submission occurred.
Why It Matters
This filing indicates that Silence Therapeutics held a vote of its security holders, which could have implications for corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose material financial or operational changes, thus posing a low immediate risk.
Key Players & Entities
- Silence Therapeutics plc (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Silence Therapeutics' security holders?
The filing does not specify the exact matters that were submitted to a vote of security holders.
When was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 26, 2025.
What is the Commission File Number for Silence Therapeutics plc?
The Commission File Number for Silence Therapeutics plc is 001-39487.
Where is Silence Therapeutics plc's principal executive office located?
Silence Therapeutics plc's principal executive office is located at 72 Hammersmith Road, London, United Kingdom, W14 8TH.
What is the SIC code for Silence Therapeutics plc?
The Standard Industrial Classification (SIC) code for Silence Therapeutics plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Silence Therapeutics plc (SLNCF).